The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However, access ...

Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy are holding back sales at the pharma ...

Weight loss drugs like Ozempic and Mounjaro could reshape food delivery habits, as users report eating smaller portions, ...

Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a ...